---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-033159"
form_type: "8-K"
ticker: "COYA"
cik: "0001835022"
company_name: "Coya Therapeutics, Inc."
filed_at: "2024-03-19T23:59:59+00:00"
generated_at: "2026-06-04T13:44:26.492573+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Coya Therapeutics reports FY2023 net loss of $8.0M; cash $32.6M plus $7.5M upfront from Dr. Reddy's

## Summary
- Net loss improved to $8.0M in FY2023 from $12.2M in FY2022; R&D spend $5.5M, G&A $7.8M.
- Cash and equivalents $32.6M at Dec 31, 2023; plus $7.5M upfront from Dr. Reddy's received Jan 2024.
- Closed Jan 2023 IPO net $14.1M and Dec 2023 private placement net $24.0M.
- Dr. Reddy's collaboration for COYA 302 in ALS: up to $733M milestones plus low-to-mid teens royalties.
- IND for COYA 302 in ALS expected 2Q24; Ph.2 topline data targeted for 2025.

## SEC filing metadata
- accession: 0000950170-24-033159
- form_type: 8-K
- ticker: COYA
- cik: 0001835022
- company_name: Coya Therapeutics, Inc.
- filed_at: 2024-03-19T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1835022/000095017024033159/0000950170-24-033159-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1835022/000095017024033159/coya-20240319.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-033159
- JSON: https://secwatch.observer/filing/0000950170-24-033159.json
- Plain text: https://secwatch.observer/filing/0000950170-24-033159.txt

## Key facts
- Earnings Releases
  Coya Therapeutics, Inc. reported financial results for the year ended December 31, 2023.
  - Period: the year ended December 31, 2023
  - Result: reported results
  source text: On March 19, 2024, Coya Therapeutics, Inc. (the “Company”) issued a press release disclosing certain information regarding its results of operations for the fiscal year ended December 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1835022/000095017024033159/0000950170-24-033159-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.